Error message

The page you requested does not exist. For your convenience, a search was performed using the query cbssm med umich edu people christian vercler md ma.

Page not found

You are here

The Genetics in Primary Care Institute recently launched its new website, featuring co-chairperson Beth Tarini, M.D., assistant professor of pediatrics at the University of Michigan’s C.S. Mott Children’s Hospital.

Along with Robert Saul, M.D., Tarini co-chairs the Institute, which aims to take genetic advances made during the last decade and help make them useful in the practice of primary care pediatrics.

The new website, www.geneticsinprimarycare.org, features information for primary care providers related to genetics testing, ethical, legal and social issues, patient communication and family history.

Tarini’s research focuses on the communication process and the health outcomes associated with genetic testing in pediatrics. She is particularly interested in pediatric population-based screening programs, such as newborn screening. Through her research, Tarini seeks to optimize communication about genetic testing between parents and providers in an effort to maximize health and minimize harm.

The UMHS press release can be found here. Dr. Tarini's featured page can be found here

Sarah Hawley, Ph.D., M.P.H., associate professor of internal medicine and a research investigator at the Ann Arbor VA, recently received a 3-year American Cancer Society grant totaling more than $850,000 for her proposal, "Population Based Study of Breast Cancer Decision Support Networks." The study will examine how informal decision supporters (e.g., partners, family, and friends) contribute decisions about surgery, radiation, and chemotherapy treatment, and how these roles may vary by race and ethnicity. The project will utilize existing resources from the Cancer Surveillance and Outcomes Research Team's (CanSORT) Program Project Grant "The Challenge of Individualizing Treatments for Patients with Breast Cancer," a $13 million award received from NCI in 2012. CanSORT and IHPI co-investigators on the study are Steven Katz, M.D., M.P.H., Nancy Janz, Ph.D., Jennifer Griggs, M.D., M.P.H., and Yun Li, Ph.D.

Thu, December 08, 2016

Reshma Jagsi, MD, discusses the risk of complications on patients receiving radiation therapy if they've had implant reconstruction. Radiation therapy may affect outcomes of breast construction, and more is needed to help patients make informed choices.

San Antonio Breast Cancer Symposium (SABCS) Presentation Title: Impact of radiotherapy on complications and patient-reported satisfaction with breast reconstruction: Findings from the prospective multicenter MROC study

Tue, April 10, 2018

In light of the #MeToo campaign denouncing sexual assault and harassment, Reshma Jagsi, MD, DPhil has written a perspective piece in the New England Journal of Medicine about sexual harrassment in academic medicine. This perspective piece and a recent survey published in JAMA related to sexual harassment and gender bias in academic medicine has been highlighted in multiple media outlets.

Funded by Brigham and Women's Hospital/Boston Univerity/NIH.

Funding Years: 2010-2013. 

In this continuation of the REVEAL Study, we will conduct a new randomized clinical trial to determine the psychological and health behavior changes associated with disclosing APOE genotype and 3-year Risk estimates to persons with mild memory problems. We will also create a new instrument that clinicians and researchers can use to reliably evaluate a patient's capacity to consent to genetic testing and examine long-term impact of genetic Risk assessment by following REVEAL Study patients 2-10 years following disclosure. For more information, visit NIH Reporter Link

PI(s): J. Scott Roberts 

Funded by Department of Veterans Affairs

Funding Year: 2012

Successful diabetes management is dependent on the patient - provider partnership. However, a full discussion of potential benefits, harms, costs, and burdens associated with each medication option is often too much for a brief clinic visit. This project uses AHRQ-developed consumer guides as inspiration for a tailored program that assists with this decision-making. The current iDECIDE intervention serves as the base of the program, with updates geared toward making it more specific to veterans.

Aim 1: Update current iDECIDE program to make it more appropriate for the VA setting. 

Angela Fagerlin (PI)

Center for Health Communications Research (CHCR) Project

 

Gina Bravo, PhD

Alumni

Gina Bravo was a Visiting Scholar at CBSSM, 2011-2012. She has a PhD in mathematics and post-doctoral training in clinical epidemiology. Professor of Public Health at the University of Sherbrooke since 1991, she teaches research methods and biostatistics to MSc and PhD candidates. She is a member of the Research Centre on Aging located within the University Institute of Geriatrics of Sherbrooke. She has received personal research awards and peer-reviewed grants from the Quebec Health Research funding agency and the Canadian Institutes of Health Research.

Last Name: 
Bravo

Funded by the National Institutes of Health

Funding years: 2008-2013

The specific aims are: 1) To test the effectiveness of a preference-tailored (PT) vs. standard information (SI) intervention for increasing primary care patient's CRC screening adherence in a randomized controlled trial at two locations; 2) To assess the impact of the intervention on informed decision making, knowledge and attitudes toward screening, decisional outcomes, and intention to get screened; and 3) To conduct a cost effectiveness analysis of the PT intervention for increasing CRC screening. For more information, visit NIH Reporter

PI: Sarah Hawley

Co-Is: Angela Fagerlin, Victor Strecher

CBSSM's Co-Director Angela Fagerlin, Ph.D., has been named one of "25 Champions of Shared Decision Making." According to the Informed Medical Decisions Foundation, "Angie has spent her career testing methods for communicating the risks and benefits of treatment options to patients, especially through decision aids. Based on the knowledge she has gained, Angie developed and tested decision aids for prostate cancer and breast cancer prevention. Her work has truly advanced the field of risk communication and patient-physician communication." 

Congratulations Angie! You can view the list here

Salomeh Michelle Salari, MS

Fellow

Sally is a fourth year medical student at the University of Michigan with the intent of specializing in Obstetrics and Gynecology. She is a member of the "Pathway of Excellence" ethics co-curricular program and is the CBSSM's second pre-doctoral clinical ethics fellow. Her interests include preventative ethics and moral distress, for which she is piloting "Moral Distress (MoD) Rounds" on non-intensive patient units at Mott Hospital.

Last Name: 
Salari

Pages